Table 1.
Estimated prevalence according to age and neovascular age-related macular degeneration (nvAMD) in populations of European ancestry.
| Age (Years) | Predicted Prevalence % (nvAMD) | Range |
|---|---|---|
| 50 | 0.04 | 0.02–0.07 |
| 55 | 0.08 | 0.05–0.13 |
| 60 | 0.17 | 0.11–0.25 |
| 65 | 0.34 | 0.23–0.49 |
| 70 | 0.7 | 0.48–0.97 |
| 75 | 1.4 | 0.99–1.90 |
| 80 | 2.79 | 1.99–3.79 |
| 85 | 5.48 | 3.91–7.45 |
| 90 | 10.49 | 7.45–14.37 |
Prevalence estimates are based on using International Classification or Wisconsin Age-Related Maculopathy Grading system together with fundus photography/imaging. Data obtained from Rudnicka et al [13].